Tower Research Capital (TRC)’s Reviva Pharmaceuticals RVPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $543 | Sell |
1,424
-6,823
| -83% | -$2.6K | ﹤0.01% | 4997 |
|
|
2025
Q1 | $7.87K | Sell |
8,247
-18,528
| -69% | -$17.7K | ﹤0.01% | 3927 |
|
|
2024
Q4 | $48.5K | Buy |
26,775
+23,953
| +849% | +$43.4K | ﹤0.01% | 2573 |
|
|
2024
Q3 | $4.06K | Buy |
2,822
+2,432
| +624% | +$3.5K | ﹤0.01% | 4692 |
|
|
2024
Q2 | $499 | Buy |
+390
| New | +$499 | ﹤0.01% | 5314 |
|
|
2024
Q1 | – | Sell |
-38,043
| Closed | -$196K | – | 6100 |
|
|
2023
Q4 | $196K | Buy |
+38,043
| New | +$196K | ﹤0.01% | 2109 |
|
|
2023
Q3 | – | Sell |
-11,109
| Closed | -$65.1K | – | 6168 |
|
|
2023
Q2 | $65.1K | Buy |
11,109
+9,590
| +631% | +$56.2K | ﹤0.01% | 2346 |
|
|
2023
Q1 | $6K | Sell |
1,519
-8,518
| -85% | -$33.6K | ﹤0.01% | 4867 |
|
|
2022
Q4 | $43K | Buy |
10,037
+5,766
| +135% | +$24.7K | ﹤0.01% | 2470 |
|
|
2022
Q3 | $7K | Sell |
4,271
-2,634
| -38% | -$4.32K | ﹤0.01% | 4921 |
|
|
2022
Q2 | $8K | Buy |
6,905
+6,465
| +1,469% | +$7.49K | ﹤0.01% | 4702 |
|
|
2022
Q1 | $1K | Sell |
440
-3,386
| -88% | -$7.7K | ﹤0.01% | 5849 |
|
|
2021
Q4 | $11K | Buy |
+3,826
| New | +$11K | ﹤0.01% | 4447 |
|
|
2021
Q3 | – | Sell |
-12,484
| Closed | -$61K | – | 6111 |
|
|
2021
Q2 | $61K | Buy |
12,484
+10,408
| +501% | +$50.9K | ﹤0.01% | 2862 |
|
|
2021
Q1 | $12K | Buy |
2,076
+2,016
| +3,360% | +$11.7K | ﹤0.01% | 4274 |
|
|
2020
Q4 | $1K | Sell |
60
-35
| -37% | -$583 | ﹤0.01% | 5029 |
|
|
2020
Q3 | $1K | Hold |
95
| – | – | ﹤0.01% | 4728 |
|
|
2020
Q2 | $1K | Hold |
95
| – | – | ﹤0.01% | 4635 |
|
|
2020
Q1 | $1K | Buy |
+95
| New | +$1K | ﹤0.01% | 2830 |
|
|
2019
Q2 | – | Sell |
-2
| Closed | – | – | 4193 |
|
|
2019
Q1 | $0 | Buy |
+2
| New | – | ﹤0.01% | 4208 |
|